HK2 and colon adenocarcinoma: Zhong et al. [44] showed that ERS acts protectively against apoptosis induced by the HK2 inhibitor 3-Bromopyruvate acid (3-BP) in COAD cells, proposing it as a promising strategy for combination therapy.